S100A16 and pancreatic neoplasm: A comprehensive analysis of the four scientific studies that met the selection criteria showed that the negative correlation level was 477.5, and the p-value was 4.37e−4, indicating that compared with all normal tissues, the expression level of S100A16 in pancreatic tumors increased (Figure 2B, P < 0.01).